Credit Capital Investments LLC Incyte Corp Transaction History

Credit Capital Investments LLC

  • $80.9 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$57.77 - $65.93 $187,752 - $214,272
3,250 Added 50.33%
9,708 $560,000
Q1 2023

May 15, 2023
BUY
$70.23 - $86.01 $453,545 - $555,452
6,458 New
6,458 $466,000
Q3 2022

Nov 14, 2022
BUY
$66.18 - $82.86 $264,720 - $331,440
4,000 New
4,000 $267,000

Others Institutions Holding INCY

# of Institutions
643
Shares Held
186M
Call Options Held
714K
Put Options Held
557K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Credit Capital Investments LLC Portfolio

Follow Credit Capital Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Capital Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Credit Capital Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email